PATIENT ALERT: We now require all patients and visitors to complete our online pre-COVID screening 72 hours prior to your appointment. Please CLICK HERE to complete the questionnaire.  Masks are still required in all offices.   Information regarding COVID-19.  The Port Warwick office telephone lines will be down for maintenance on Thursday, May 26th, from 5:30pm-6:30pm. If you need to contact a VOA physician during this time, please dial 757-594-2000 and ask for the on-call physician.

About Us

Contributing Artists

Jan 26, 2022

Over the past few months, we have relocated two of our Virginia Oncology Associates offices. Our former Lake Wright office is now located in the Brock Cancer Center in Norfolk. Our Chesapeake office moved from Volvo Parkway to the Priority Toyota Cancer Center on the CRMC campus off of Battlefield Blvd. Rather than purchasing artwork from a retailer, we held a contest that included our staff and patients asking them to submit photographs that would potentially be chosen to live on the walls at our cancer centers.

Read more


Virginia Oncology Associates Announces Relocation of Norfolk Office to Sentara Brock Cancer Center

Apr 28, 2021

The collaborative facility allows physician-owned Virginia Oncology Associates, Sentara Healthcare, and other medical providers to deliver multi-disciplinary care to the community.

Norfolk, VA – April 2021 Virginia Oncology Associates Norfolk office, now located in the Sentara Brock Cancer Center, has opened their doors and is welcoming patients. VOA remains an independent, physician-owned practice caring for patients with cancer and blood disorders, offering treatment from nine offices located throughout the Hampton Roads area and Eastern North Carolina.

Read more


Important Note on Drug Costs to VOA Patients

Mar 22, 2021

Virginia Oncology Associates is working with the US Oncology Network to lower drug costs for our patients with cancer.  While we do not set the pricing for drugs, we do have opportunities to choose which brand or version of a given drug we will stock.  In so doing, we support competition among the manufacturers which drives down the cost for both patients and for the insurance companies.

Read more